PMID- 20384725 OWN - NLM STAT- MEDLINE DCOM- 20101221 LR - 20101102 IS - 1528-1167 (Electronic) IS - 0013-9580 (Linking) VI - 51 IP - 10 DP - 2010 Oct TI - Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy? PG - 2084-8 LID - 10.1111/j.1528-1167.2010.02557.x [doi] AB - PURPOSE: We used transcranial magnetic stimulation (TMS) to investigate whether there were any characteristic cortical excitability changes in progressive myoclonic epilepsy (PME) compared to juvenile myoclonic epilepsy (JME). METHODS: Six patients with PME were studied. Motor threshold (MT) at rest and recovery curve analysis using paired-pulse stimulation at a number of interstimulus intervals (ISIs) was determined. Results were compared to those of 9 patients with chronic refractory JME and 10 with chronic well-controlled JME. RESULTS: PME showed a marked increase in cortical excitability at all the long ISIs (p < 0.01), compared to refractory JME (effect sizes ranging from 1.4 to 1.9) and well-controlled JME (effect sizes ranging from 2.0 to 2.4). Significant differences at the short ISIs 2-5 ms were seen only on comparison with the well-controlled group (p < 0.05, effect size 0.6, 0.7). There were no significant differences in MTs of PME compared to either JME groups. CONCLUSION: Our findings demonstrate specific differences in cortical excitability using TMS between PME and those with JME, particularly at long latencies in the paired-pulse paradigm, implicating a role for gamma-aminobutyric acid (GABA)(B) -mediated networks. CI - Wiley Periodicals, Inc. (c) 2010 International League Against Epilepsy. FAU - Badawy, Radwa A B AU - Badawy RA AD - Department of Neurology, Austin Health, Heidelberg, Victoria, Australia. FAU - Macdonell, Richard A L AU - Macdonell RA FAU - Jackson, Graeme D AU - Jackson GD FAU - Berkovic, Samuel F AU - Berkovic SF LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Epilepsia JT - Epilepsia JID - 2983306R RN - 0 (Anticonvulsants) RN - 56-12-2 (gamma-Aminobutyric Acid) SB - IM MH - Adult MH - Anticonvulsants/therapeutic use MH - Cerebral Cortex/physiopathology MH - Chronic Disease MH - Diagnosis, Differential MH - Drug Resistance MH - Female MH - Humans MH - Male MH - Middle Aged MH - Motor Cortex/*physiopathology MH - Myoclonic Epilepsies, Progressive/*diagnosis/drug therapy/physiopathology MH - Myoclonic Epilepsy, Juvenile/*diagnosis/drug therapy/physiopathology MH - Transcranial Magnetic Stimulation/methods/*statistics & numerical data MH - Unverricht-Lundborg Syndrome/diagnosis/physiopathology MH - gamma-Aminobutyric Acid/physiology EDAT- 2010/04/14 06:00 MHDA- 2010/12/22 06:00 CRDT- 2010/04/14 06:00 PHST- 2010/04/14 06:00 [entrez] PHST- 2010/04/14 06:00 [pubmed] PHST- 2010/12/22 06:00 [medline] AID - EPI2557 [pii] AID - 10.1111/j.1528-1167.2010.02557.x [doi] PST - ppublish SO - Epilepsia. 2010 Oct;51(10):2084-8. doi: 10.1111/j.1528-1167.2010.02557.x.